Peak Financial Advisors LLC Reduces Position in Mettler-Toledo International Inc. (NYSE:MTD)

Peak Financial Advisors LLC trimmed its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 58.7% during the fourth quarter, HoldingsChannel reports. The firm owned 859 shares of the medical instruments supplier’s stock after selling 1,221 shares during the period. Peak Financial Advisors LLC’s holdings in Mettler-Toledo International were worth $1,051,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. State Street Corp increased its stake in Mettler-Toledo International by 1.0% during the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock worth $1,431,693,000 after buying an additional 9,009 shares during the period. Geode Capital Management LLC raised its stake in shares of Mettler-Toledo International by 0.8% in the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after acquiring an additional 4,166 shares in the last quarter. Barclays PLC increased its holdings in Mettler-Toledo International by 8.3% during the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock worth $384,822,000 after purchasing an additional 19,609 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Mettler-Toledo International by 14.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after buying an additional 28,478 shares during the period. Finally, Loomis Sayles & Co. L P increased its stake in shares of Mettler-Toledo International by 1.8% during the third quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock worth $314,790,000 after buying an additional 3,644 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

MTD has been the subject of a number of recent research reports. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Wolfe Research started coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating for the company. Stifel Nicolaus dropped their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a report on Monday, November 11th. Wells Fargo & Company decreased their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Finally, Robert W. Baird dropped their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $1,351.25.

Mettler-Toledo International Stock Performance

MTD opened at $1,270.91 on Wednesday. Mettler-Toledo International Inc. has a one year low of $1,133.46 and a one year high of $1,546.93. The stock has a market capitalization of $26.82 billion, a P/E ratio of 34.27, a price-to-earnings-growth ratio of 4.21 and a beta of 1.12. The business’s 50-day simple moving average is $1,246.46 and its 200-day simple moving average is $1,345.43.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping the consensus estimate of $10.00 by $0.21. The company had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. On average, equities research analysts forecast that Mettler-Toledo International Inc. will post 40.42 EPS for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now directly owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 140 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the transaction, the insider now directly owns 6 shares in the company, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.